OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
Vianney Tricou, Delia Yu, Humberto Reynales, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 2, pp. e257-e270
Open Access | Times Cited: 75
Vianney Tricou, Delia Yu, Humberto Reynales, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 2, pp. e257-e270
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Introduction of Vector-Borne Infections in Europe: Emerging and Re-Emerging Viral Pathogens with Potential Impact on One Health
Jacopo Logiudice, Maria Antònia Albertí, A. M. Ciccarone, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 1
Jacopo Logiudice, Maria Antònia Albertí, A. M. Ciccarone, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 1
Advances in the Epidemiology, Pathogenesis, Diagnostic Methods, and Vaccine Development of Dengue Fever: A Comprehensive Review
Boqi Dong, Sisi Feng, Xianmin Feng
Viral Immunology (2025)
Closed Access | Times Cited: 1
Boqi Dong, Sisi Feng, Xianmin Feng
Viral Immunology (2025)
Closed Access | Times Cited: 1
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden
Annelies Wilder‐Smith
The Lancet Global Health (2024) Vol. 12, Iss. 2, pp. e179-e180
Open Access | Times Cited: 11
Annelies Wilder‐Smith
The Lancet Global Health (2024) Vol. 12, Iss. 2, pp. e179-e180
Open Access | Times Cited: 11
Brazil’s record dengue surge: why a vaccine campaign is unlikely to stop it
Mariana Lenharo
Nature (2024) Vol. 627, Iss. 8003, pp. 250-251
Closed Access | Times Cited: 11
Mariana Lenharo
Nature (2024) Vol. 627, Iss. 8003, pp. 250-251
Closed Access | Times Cited: 11
Mechanisms of antibody-dependent enhancement of infectious disease
Timothy J. Wells, Tyron Esposito, Ian R. Henderson, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 10
Timothy J. Wells, Tyron Esposito, Ian R. Henderson, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 10
An Update on the Entomology, Virology, Pathogenesis, and Epidemiology Status of West Nile and Dengue Viruses in Europe (2018–2023)
Federica Frasca, Leonardo Sorrentino, Matteo Fracella, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 7, pp. 166-166
Open Access | Times Cited: 8
Federica Frasca, Leonardo Sorrentino, Matteo Fracella, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 7, pp. 166-166
Open Access | Times Cited: 8
Characterisation of ten NS2B-NS3 proteases: Paving the way for pan-flavivirus drugs
Saan Voss, Jörg Rademann, Christoph Nitsche
Antiviral Research (2024) Vol. 226, pp. 105878-105878
Open Access | Times Cited: 7
Saan Voss, Jörg Rademann, Christoph Nitsche
Antiviral Research (2024) Vol. 226, pp. 105878-105878
Open Access | Times Cited: 7
Molecular mechanisms in the pathogenesis of dengue infections
Gathsaurie Neelika Malavige, Graham S. Ogg
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 484-498
Closed Access | Times Cited: 7
Gathsaurie Neelika Malavige, Graham S. Ogg
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 484-498
Closed Access | Times Cited: 7
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination
Chukiat Sirivichayakul, Shibadas Biswal, Xavier Sáez‐Llorens, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 6
Chukiat Sirivichayakul, Shibadas Biswal, Xavier Sáez‐Llorens, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 6
Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil
Maurício Lacerda Nogueira, Monica A T Cintra, J. A. A. Moreira, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1234-1244
Closed Access | Times Cited: 6
Maurício Lacerda Nogueira, Monica A T Cintra, J. A. A. Moreira, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1234-1244
Closed Access | Times Cited: 6
Quadrivalent dengue-virus vaccines: challenges and opportunities for India
Guruprasad R. Medigeshi, Farzana Islam, Rakesh Lodha
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. e270-e271
Open Access | Times Cited: 5
Guruprasad R. Medigeshi, Farzana Islam, Rakesh Lodha
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. e270-e271
Open Access | Times Cited: 5
Delivering safe dengue vaccines
Scott B. Halstead
The Lancet Global Health (2024) Vol. 12, Iss. 8, pp. e1229-e1230
Open Access | Times Cited: 5
Scott B. Halstead
The Lancet Global Health (2024) Vol. 12, Iss. 8, pp. e1229-e1230
Open Access | Times Cited: 5
Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective
Camila D. Odio, Jedas Veronica Daag, Maria Vinna Crisostomo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Camila D. Odio, Jedas Veronica Daag, Maria Vinna Crisostomo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Equipmentless point-of-care testing of dengue antibodies using ELISA and smartphones
Diego Mendicino, Christian A. Avalos, Romina Chiaraviglio, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 255, pp. 116666-116666
Closed Access
Diego Mendicino, Christian A. Avalos, Romina Chiaraviglio, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 255, pp. 116666-116666
Closed Access
Panorama del Dengue en Suramérica: Incidencia, Características Clínicas y Estrategias de Prevención
Beatríz Quintero, Sonia Michelle Guarderas-Gonzaga, María Augusta Lima-Machuca
Bionatura journal : (2025) Vol. 2, Iss. 1, pp. 1-19
Closed Access
Beatríz Quintero, Sonia Michelle Guarderas-Gonzaga, María Augusta Lima-Machuca
Bionatura journal : (2025) Vol. 2, Iss. 1, pp. 1-19
Closed Access
Assessing the Efficacy of Dengue Vaccine: A Comprehensive Literature Review
Angelia Agustina, Cut Nur Cinthia Alamanda
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2025) Vol. 31, Iss. 2, pp. 196-200
Open Access
Angelia Agustina, Cut Nur Cinthia Alamanda
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2025) Vol. 31, Iss. 2, pp. 196-200
Open Access
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
Kam W. Leong, Seng Kong Tham, Chit Laa Poh
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Kam W. Leong, Seng Kong Tham, Chit Laa Poh
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis
Maria Elena Flacco, Alessandro Bianconi, Giovanni Cioni, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 770-770
Open Access | Times Cited: 4
Maria Elena Flacco, Alessandro Bianconi, Giovanni Cioni, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 770-770
Open Access | Times Cited: 4
The role of antibody-dependent enhancement in dengue vaccination
Dagnew Mersha, I. van der Sterren, Leanne P. M. van Leeuwen, et al.
Tropical Diseases Travel Medicine and Vaccines (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Dagnew Mersha, I. van der Sterren, Leanne P. M. van Leeuwen, et al.
Tropical Diseases Travel Medicine and Vaccines (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Heterologous Prime-Boost immunization with Adenoviral vector and recombinant subunit vaccines strategies against dengue virus type2
M Mahmoudian Shoushtari, Mostafa Salehi‐Vaziri, Maryam Kadkhodazadeh, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114032-114032
Closed Access
M Mahmoudian Shoushtari, Mostafa Salehi‐Vaziri, Maryam Kadkhodazadeh, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114032-114032
Closed Access
A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
B. Ghezzi, Cristina Valencia, Roberto Dias de Oliveira, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 121-121
Open Access
B. Ghezzi, Cristina Valencia, Roberto Dias de Oliveira, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 121-121
Open Access
Tetravalent Virus-like Particles Engineered To Display Envelope Domain IIIs of Four Dengue Serotypes in Silkworm as Vaccine Candidates
Krishna Raja Muthuraman, Jirayu Boonyakida, Mami Matsuda, et al.
Biomacromolecules (2025)
Closed Access
Krishna Raja Muthuraman, Jirayu Boonyakida, Mami Matsuda, et al.
Biomacromolecules (2025)
Closed Access
Immunogenomics of Dengue Fever and Association to Physiopathology and Disease Control
Raquel da Silva Carvalho, João Gustavo Machado Miranda, Raísa Melo Lima, et al.
IntechOpen eBooks (2025)
Closed Access
Raquel da Silva Carvalho, João Gustavo Machado Miranda, Raísa Melo Lima, et al.
IntechOpen eBooks (2025)
Closed Access
Daidzin protects against dengue virus infection by targeting viral envelope protein
Xuemei He, Bing Chen, Jingtao Yu, et al.
Industrial Crops and Products (2025) Vol. 226, pp. 120658-120658
Open Access
Xuemei He, Bing Chen, Jingtao Yu, et al.
Industrial Crops and Products (2025) Vol. 226, pp. 120658-120658
Open Access
